兰陵王

China's pharmaceutical industry sees accelerated innovation breakthroughs in H1_我的网站

一 |     (ECNS) -- China's pharmaceutical industry accelerated innovation in the first half of this year, with domestic companies steadily improving their R&D capabilities and growth momentum continuing to strengthen, data showed.    China's first broad-spectrum targeted anticancer drug entered clinical use at major hospitals across the country this year. It took only eight months to go from submission to market approval.    A total of 38 innovative drugs were approved for marketing in China in the first half, of which 31 were developed domestically, more than 80% of the total. Eleven drugs featuring new targets or new mechanisms were all developed independently by domestic companies, producing a number of world-first innovations. By the end of 2025, China had 4,751 innovative drugs under development, one-third of the global total and the largest pipeline of any country.    Behind this concentration of results lies a steadily strengthening industrial base. China has a complete pharmaceutical supply chain. It is not only the world's largest producer of active pharmaceutical ingredients but has also built a production system covering every pharmaceutical category.    This year, digital, intelligent, and green technologies have driven the industry's transformation and upgrading.     At a biopharmaceutical company in Shanxi Province, a newly built AI-powered bio-computing center can identify the structures of millions of protein functional domains in a short time, screening out ineffective molecules directly.    To date, China has supported 21 pharmaceutical firms in building excellent-level smart factories and has cultivated more than 300 green factories. In the first half, the added value of pharmaceutical enterprises above the designated scale grew 6.4% year on year, and exports held strong.    The world's first chemotherapy-sparing drug for gastric cancer, launched this year, had already earned overseas revenue through licensing deals before it reached the market, and is now exported to multiple countries and regions.    In the first half, the total value of China's innovative drug out-licensing deals reached $110 billion, the industry's export delivery value grew 9% year on year, and high-value-added products made up nearly 20% of the total.        (By Tang Yuxian)                    。    本网讯 邸航 记者王雪娇报道          　　入汛以来，马仗房街道高度重视防汛工作，积极做好应急物资储备，加大防汛宣传力度，全力打好防汛“准备仗”，筑牢防汛“安全堤”。         　　日前，记者走进建北社区防汛应急安置点看到，折叠床、被褥、救生衣、雨披等各种防汛物资种类齐全。

二 | 同时，马仗房街道工作人员还对物资保管养护情况开展检查，确保物资数量充足。         　　据了解，马仗房街道大部分属于老旧小区，针对这一情况，街道召开防汛部署会议，分析防汛工作新形势、新状况，对街道易积涝点、排水淤堵点等情况研究制定应对处置措施，完善各项防汛预案，以“迅”应“汛”，保障人民生命财产安全。

三 | 同时，还加大防汛工作宣传力度，深入居民家中讲解避险常识，增强大家安全防范意识，切实保障辖区居民“风雨无忧”。         　　针对防汛工作，马仗房街道一直密切关注天气变化和雨情水情动态，持续做好防汛隐患排查和应急准备等各项工作，筑牢防汛‘安全堤’，为群众撑起‘安全伞’，确保今年安全度汛。

Current article:http://pxba.shaihanhuangwoshang.cyou/news/20260826_946574.html

Published on:09:52:51